Serum adiponectin and leptin levels in Taiwanese breast cancer patients

Cancer Letters

Volumn 237, Issue 1, 2006, Pages 109-114

  Chen, Da Chung ^a   Chung, Yueh Fang ^a,b   Yeh, Yao Tsug ^a   Chaung, Hso Chi ^b   Kuo, Fu Chen ^a   Fu, Ou Yang ^c   Chen, Hue Yong ^d   Hou, Ming Feng ^c   Yuan, Shyng Shou F ^a  

^a E DA HOSPITAL   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Body mass index; Breast cancer; Leptin

Indexed keywords

ADIPONECTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LEPTIN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; HORMONE BLOOD LEVEL; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STUDENT T TEST; TUMOR VOLUME;

ADIPONECTIN; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; BREAST NEOPLASMS; DEMOGRAPHY; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; NEOPLASM INVASIVENESS; TAIWAN;

EID: 33646497663     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.047     Document Type: Article

References (32)

1. Miyoshi Y., Funahashi T., Kihara S., Taguchi T., Tamaki Y., and Noguchi S. Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9 (2003) 5699-5704
2. Mantzoros C., Petridou E., Dessypris N., Chavelas C., Dalamaga M., Alexe D.M., et al. Adiponectin and breast cancer risk. Clin. Endocrinol. Metab. 89 (2004) 1102-1107
3. Matsubara M., Maruoka S., and Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur. J. Endocrinol. 147 (2002) 173-180
4. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1), Biochem. Biophys. Res. Commun. 221 (1996) 286-289
5. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., and Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. (Tokyo) 120 (1996) 803-812
6. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
7. Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, acts as a platelets growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
8. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
9. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific Protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
10. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Plasma adiponectin levels in overweight and obese. Asian Obes. Res. 10 (2002) 1104-1110
11. Markowska A., Malendowicz K., and Drews K. The role of leptin in breast cancer. Eur. J. Gynaecol. Oncol. 25 (2004) 192-194
12. Hardwick J.C., Van Den Brink G.R., Offerhaus G.J., Van Deventer S.J., and Peppelenbosch M.P. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121 (2001) 79-90
13. Emilsson V., Liu Y.L., Cawthorne M.A., Morton N.M., and Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islet and direct inhibitory action of leptin on insulin secretion. Diabetes 46 (1997) 313-316
14. Briscoe C.P., Hanif S., Arch J.R., and Tadayyon M. Leptin receptor longform signaling in a human liver cell line. Cytokine 14 (2001) 225-229
15. Tessitore L., Vizio B., Jenkins O., De Stefano I., Ritossa C., Argiles J.M., and Benedetto C. Leptin expression in colorectal and breast cancer patients. Int. J. Mol. Med. 5 (2000) 421-426
16. Coskun U., Gunel N., Toruner F.B., Sancak B., Onuk E., Bayram O., et al. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 50 (2003) 41-46
17. Mantzoros C.S., Bolhke K., Moschos S., and Cramer D.W. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int. J. Cancer 80 (1999) 523-526
18. Petridou E., Papadiamantis Y., Markopoulos C., Spanos E., Dessypris N., and Trichopoulos D. Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11 (2000) 383-388
19. Hou M.F., Chen S.T., Chen J.C., Yeh K.T., Lee T.P., Chen C.M., et al. Sulfotransferase 1A2*2 is a risk factor for early-onset breast cancer. Int. J. Mol. Med. 10 (2002) 609-612
20. World Health Organization. The World Health Organization histological typing of breast tumors-second edition. Am. J. Clin. Pathol. 788 (1982) 806-816
21. Elston C.W. Grading of invasive carcinoma of the breast. In: Page D.L., and Anderson T.J. (Eds). Diagnostic Histopathology of the Breast (1987), Churchill Livingstone, Edinburgh 300-311
22. Hou M.F., Lin S.B., Yuan S.S.F., Tsai S.M., Wu S.H., Yang F.O., et al. The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin. Chim. Acta 334 (2003) 137-144
23. Chan T.F., Yuan S.S.F., Chen H.S., Guu C.F., Wu L.C., Yeh Y.T., et al. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet. Gynecol. Scand. 83 (2003) 165-169
24. Chan T.F., Su J.H., Chung Y.F., Chang H.L., and Yuan S.S.F. Decreased serum leptin levels in women with uterine leiomyomas. Acta Obstet. Gynecol. Scand. 82 (2003) 173-176
25. Calle E.E., Rodriquez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N. Eng. J. Med. 348 (2003) 1625-1638
26. Cleary M.P., and Maihle N.J. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc. Soc. Exp. Biol. Med. 216 (1997) 28-43
27. Okumura M., Yamamoto M., Sakuma H., Kojima T., Maruyama T., Jamali M., et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim. Biophys. Acta 1592 (2002) 107-116
28. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001) 941-946
29. Brakenhielm E., Veitonmaki N., Cao R., Kihara S., Matsuzawa Y., Zhivotovsky B., et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl Acad. Sci. USA 101 (2004) 2476-2481
30. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
31. Bouloumie A., Drexler H.C., Lafontan M., and Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83 (1998) 1059-1066
32. Artwohl M., Roden M., Holzenbein T., Freudenthaler A., Waldhausl W., and Baumgartner-Parzer S.M. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 577-580